Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 16, Pages 3691-3697
Publisher
American Society of Hematology
Online
2012-01-21
DOI
10.1182/blood-2011-06-363556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults
- (2011) M. Crowther et al. BLOOD
- How I manage cold agglutinin disease
- (2011) Sigbjørn Berentsen BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab therapy for autoimmune haematological diseases
- (2011) Wilma Barcellini et al. European Journal of Internal Medicine
- Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders
- (2010) Daan Dierickx et al. AMERICAN JOURNAL OF HEMATOLOGY
- Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia
- (2010) Francisco Javier Peñalver et al. ANNALS OF HEMATOLOGY
- High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
- (2010) S. Berentsen et al. BLOOD
- Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias
- (2010) D. Gomez-Almaguer et al. BLOOD
- Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
- (2010) F. Zaja et al. BLOOD
- How I treat autoimmune hemolytic anemias in adults
- (2010) K. Lechner et al. BLOOD
- Low-dose rituximab in adult patients with primary immune thrombocytopenia
- (2010) Francesco Zaja et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
- (2010) Zhenyu Li et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
- (2010) Chen S Tan et al. LANCET NEUROLOGY
- Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation
- (2010) A. Jäger et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells
- (2010) Roberto Stasi SEMINARS IN HEMATOLOGY
- Rituximab-Associated Infections
- (2010) Juan C. Gea-Banacloche SEMINARS IN HEMATOLOGY
- Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study
- (2009) D. Dierickx et al. JOURNAL OF INTERNAL MEDICINE
- Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: Retrospective analysis of 27 cases
- (2008) Guillaume Bussone et al. AMERICAN JOURNAL OF HEMATOLOGY
- Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study
- (2008) B. Godeau et al. BLOOD
- Rituximab in the treatment of autoimmune haematological disorders
- (2008) Bernadette Garvey BRITISH JOURNAL OF HAEMATOLOGY
- Human Th17 cells
- (2008) Sergio Romagnani ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More